Compare EOG Resources Inc (EOG) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EOG Resources Inc vs Heron Therapeutics Inc — how do they compare? EOG Resources Inc trades at $148.51 (market cap $77.90B), while Heron Therapeutics Inc trades at $0.37 (market cap $68.01M). The key difference: EOG Resources Inc is far larger — about 1145.4× Heron Therapeutics Inc's market cap, and EOG Resources Inc pays a 2.75% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold EOG Resources Inc for 59 Days and Heron Therapeutics Inc for 35 Days on average.
| EOG | HRTX | |
|---|---|---|
Market Cap | $77.90B | $68.01M |
Volume | 2,930,386 | 1,891,941 |
Sector | Energy | Health |
52-Week High | $153.74 | $1.49 |
52-Week Low | $101.78 | $0.27 |
Typical Hold Time | 59 Days | 35 Days |
Enterprise Value | $81.24B | $174.75M |
Dividend Yield | 2.75% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EOG Resources trades at $144.21, down 0.05% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $164.77 implying 14% upside. The company has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $5.07 exceeding expectations, while maintaining strong profitability with a 25.81% net income margin and 22.51% ROE. Recent news highlights operational strength and disciplined capital allocation, with upcoming Q3 2026 results scheduled for November 6, 2026.
EOG presents a compelling value opportunity with attractive valuation multiples (P/E of 11.22, EV/EBITDA of 5.68) and strong shareholder returns through dividends. Key risks include oil price volatility, as seen in recent sector pullbacks, and execution of growth targets amid macroeconomic uncertainty. The absence of sell ratings from analysts and institutional accumulation support a positive medium-term outlook, though investors should monitor energy market dynamics and quarterly results.
HRTX trades at $0.39, up 17.58% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings performance discussions.
The outlook is mixed: strong analyst support and technical momentum suggest potential upside, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on revenue growth translating to profitability, while key risks include execution challenges and competitive pressures in the biotechnology sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About EOG Resources Inc
EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
Read more on EOG →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
